Lunai Bioworks Inc. (LNAI)
LNAI Stock Price Chart
Explore Lunai Bioworks Inc. interactive price chart. Choose custom timeframes to analyze LNAI price movements and trends.
LNAI Company Profile
Discover essential business fundamentals and corporate details for Lunai Bioworks Inc. (LNAI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Sept 2025
Employees
29.00
Website
http://www.renovarogroup.comCEO
David H. Weinstein
Description
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
LNAI Financial Timeline
Browse a chronological timeline of Lunai Bioworks Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 22 May 2026
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2026
EPS came in at -$0.80 , while revenue for the quarter reached $20.94k .
Earnings released on 17 Feb 2026
EPS came in at -$0.08 .
Earnings released on 14 Nov 2025
EPS came in at $0.13 .
Earnings released on 15 May 2025
EPS came in at $0.01 .
LNAI Stock Performance
Access detailed LNAI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
